At the Medicap Pharmacy® stores, we are dedicated to providing products and services to care for your family’s wellness. One of those services is health news you can trust. Use the filters to focus on the information that is important to you, then bookmark this page to make it a regular stop anytime you’re online.
Dangerous Weight Loss Linked to Common Dementia Rx
It's probably not your imagination that Grandma is becoming increasingly fragile over time. And her dementia medication may be partly to blame.
Early Signs of Alzheimer’s Disease
Memory problems may be one of the first signs of Alzheimer’s disease, but it’s not the first sign for everyone. There are several other clues that Alzheimer’s disease may be developing.
Can Dementia Meds Delay Mild Mental Decline?
Adults are living longer lives, which means more people will be living with some level of mental decline. Can that decline be delayed?
Killing Two Ills with One Pill
The dementia associated with Alzheimer’s disease cannot be cured, but medication is available to improve the ability to think and remember.
Learning How to Protect Thinking
The brain is unlike any other organ in the body. Every area of the brain affects a major part of human life. Researchers are finding ways to protect cognitive function during brain cancer surgery.
Aricept for Other Types of Dementia?
Aricept is approved for the treatment of Alzheimer’s disease, but clinical trials are underway to see if it will be helpful for other types of dementia.
Dementia Drug Doing Well
There are few medications currently approved to treat Alzheimer’s disease (AD). A new type of drug shows early promise in clinical trials.
Are Dementia Medications Safe for the Heart?
Medications for treating Alzheimer’s disease (AD) have been suspected to influence heart function. New research finds that heart function was not affected over four weeks of treatment.
Extending the use of Aricept for Alzheimer’s
Aricept ( donepezil ) is currently approved for mild to moderate Alzheimer’s Disease and is commonly taken by people in early stages of the disease. New research extends the use of the drug for people in moderate to severe stages of the disease.
Alzheimer’s Drug Phase 3 Results Not Good
Medivation , Inc. and Pfizer Inc. announced results from the CONCERT trial, which is a Phase 3 trial that evaluated Dimebon ( latrepirdine ) when added to ongoing treatment with donepezil HCL tablets in patients with mild-to-moderate Alzheimer’s disease.